Not the First Time
This is part of a broader pattern of nitrosamine-related recalls in recent years:
- In 2018, valsartan was recalled due to contamination
- In 2020, metformin faced similar issues
- Ranitidine (Zantac) was withdrawn after impurity concerns
These events pushed regulators to enforce stricter testing and manufacturing controls. Today, companies are required to demonstrate processes that minimize nitrosamine formation.
In many ways, each recall has strengthened future safety standards.
